PITTSBURGH, Sept 01, 2009 /PRNewswire-FirstCall via COMTEX News Network/ -- Mylan Inc. (Nasdaq: MYL) today announced that Mark W. Parrish, chairman and CEO of Trident USA Health Services, the nation's largest provider of mobile X-ray and laboratory services to the long-term care industry, has joined Mylan's Board of Directors. In addition to his current role at Trident, Parrish also is president of the International Federation of Pharmaceutical Wholesalers, an association comprised of the largest pharmaceutical wholesalers and pharmaceutical supply chain service companies in the world. He also serves as a senior adviser to Frazier Healthcare Ventures, a health care oriented growth equity firm, and as a director of Biovail Corporation.

Previously, Parrish was CEO of Healthcare Supply Chain Services for Cardinal Health, a $91 billion global manufacturer and distributor of medical and surgical supplies and technologies. Parrish also held a variety of other leadership roles at Cardinal Health including group president, Pharmaceutical Supply Chain Services; president and chief operating officer, Pharmaceutical Supply Chain Services; chairman and CEO, Pharmaceutical Distribution and Provider Services; executive vice president and group president, Pharmaceutical Distribution; and president, Medicine Shoppe.

"I am honored to have this tremendous opportunity to serve as a Mylan director," said Parrish. "Throughout my career, Mylan always has stood out among generic pharmaceutical manufacturers as having an unbeatable reputation for quality, reliability and affordability."

Mylan Chairman and CEO Robert J. Coury said: "I am very pleased to welcome an executive of Mark's caliber to our extremely knowledgeable board. His exceptional track record as a leader and deep familiarity with the health care sector and pharmaceutical industry make him ideally suited to help guide Mylan's continued growth. Mark's first-hand, in-depth understanding of how to create, refine and leverage supply chains and distribution channels will prove particularly valuable as we continue our efforts to expand consumers' access to our high quality products around the world."

Prior to joining Cardinal Health, Parrish held positions in health care distribution companies in the pharmaceutical and medical surgical product sectors. He earned a Bachelor of Arts degree from the University of California, Berkeley.

Mylan Inc., which provides products to customers in more than 140 countries and territories, ranks among the leading diversified generic and specialty pharmaceutical companies in the world. The company maintains one of the industry's broadest - and highest quality - product portfolios, supported by a robust product pipeline; operates the world's third largest active pharmaceutical ingredient manufacturer; and runs a specialty business focused on respiratory and allergy therapies. For more information, please visit www.mylan.com.

SOURCE Mylan Inc.

http://www.mylan.com

Copyright (C) 2009 PR Newswire. All rights reserved